Title: Chemical Synthesis Facility

This pre-solicitation notice announces the National Institute of Child Health and Human Development's intent to procure a Chemical Synthesis Facility capable of rapidly synthesizing potential anti-fertility agents on laboratory and kilogram scales under cGMP. The facility must be able to synthesize compounds from grams to ten kilograms, peptides from milligrams to kilograms, and radiolabeled compounds for pharmacokinetic studies. In collaboration with other investigators, the facility will also support development of new contraceptive methods. Interested and qualified offerors should monitor sam.gov as the RFP is expected to be issued on April 18, 2022, with proposals due around June 3, 2022.

There is no set-aside designated for this procurement. The facility will synthesize compounds from gram to ten kilogram quantities and collaborate with investigators to develop new contraceptive methods. The notice provides no budget range or details on current contractors. As the pre-eminent research institute focused on maternal and child health, the National Institute of Child Health and Human Development seeks this facility to rapidly advance contraceptive evaluation, toxicology studies, and clinical trials through controlled substance manufacturing from milligram to kilogram scales.